- Lilly announces Guidant IPO for 20% of new company's stock
- Lilly, Medtronic cross-license CV device patents
- Best Industries enters into development deal with Cordis
- Boston Scientific acquires Pfizer's Schneider for $2.1bn
- J&J buys Cordis, builds force in vascular disease management
- Sulzer Medica nets $521mm in global IPO
- Guidant licenses rights to Micro Therapeutics technologies
- Eli Lilly acquires Origin Medsystems (laparoscopic devices)
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.